Y-mAbs Therapeutics, Inc(NASDAQ:YMAB) 
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophag...
Website: http://www.ymabs.com
Founded: 2015
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-19
P
O 4.58
H 4.95
L 4.58
C 4.90
V 242,428
10EMA 4.90
20EMA 4.90
60EMA 4.90
120EMA 4.90
250EMA 4.90